Evaluation of the osteoarthritis disease burden in China from 1990 to 2021: based on the Global Burden of Disease Study 2021
ObjectiveThis study aims to understand the current status and trend of the disease burden of osteoarthritis (OA) in people over 30 years old in China from 1990 to 2021 and identify the priority population groups, to provide reference data for the prevention and treatment of OA in China.MethodsThe Gl...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Public Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2024.1478710/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849221363288506368 |
|---|---|
| author | Jiahui Liang Jiahui Liang Yue Wang Fei Yu Guichun Jiang Weiguo Zhang Weiguo Zhang Kang Tian Kang Tian |
| author_facet | Jiahui Liang Jiahui Liang Yue Wang Fei Yu Guichun Jiang Weiguo Zhang Weiguo Zhang Kang Tian Kang Tian |
| author_sort | Jiahui Liang |
| collection | DOAJ |
| description | ObjectiveThis study aims to understand the current status and trend of the disease burden of osteoarthritis (OA) in people over 30 years old in China from 1990 to 2021 and identify the priority population groups, to provide reference data for the prevention and treatment of OA in China.MethodsThe Global Burden of Disease Study 2021 was used to describe the incidence, prevalence, and disability-adjusted life years (DALYs) of OA in adult aged 30 years or older in China by sex and age groups, which was used to analyze the disease burden of OA from 1990 to 2021. The joinpoint regression model and age-period-cohort model were used to characterize the temporal trend.ResultsIn 2021, the number of OA prevalence in China was about 152.85 million, and the number of incidences was about 11.65 million. The age-standardized prevalence rate (ASPR), age-standardized incidence rate (ASIR) and age-standardized DALYs rate (ASDR) of OA in China are lower than those in developed countries such as Korea, the United States of America and Japan, but higher than those in India. Knee osteoarthritis had the highest ASPR and ASDR. The highest incidence rate was 50–54 years, and the highest prevalence and DALYs rate were in the age group of patients over 95 years old. The incidence rate of women in all age groups is higher than that of men. From 1990 to 2021, the ASIR, ASPR and ASDR of OA in China roughly showed an increasing trend year by year. The age-period-cohort analysis showed that the peak age groups for longitudinal age incidence of OA in China from 1992 to 2021 were 50–54 years and 80–84 years. We found that the OA incidence was highest in the period 2017–2021.ConclusionThe disease burden of OA in those over 30 years old in China from 1990 to 2021 will become more and more serious, and the target population for primary prevention is the female population under 50 years old. The development of a scientific and effective comprehensive prevention and treatment program for OA is imminent. |
| format | Article |
| id | doaj-art-cc233dbfcbf8435496c25fe6408dcf21 |
| institution | Kabale University |
| issn | 2296-2565 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Public Health |
| spelling | doaj-art-cc233dbfcbf8435496c25fe6408dcf212024-11-15T05:10:16ZengFrontiers Media S.A.Frontiers in Public Health2296-25652024-11-011210.3389/fpubh.2024.14787101478710Evaluation of the osteoarthritis disease burden in China from 1990 to 2021: based on the Global Burden of Disease Study 2021Jiahui Liang0Jiahui Liang1Yue Wang2Fei Yu3Guichun Jiang4Weiguo Zhang5Weiguo Zhang6Kang Tian7Kang Tian8Department of Joint and Sports Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, ChinaSchool of Graduates, Dalian Medical University, Dalian, Liaoning, ChinaThe School of Medicine, Nankai University, Tianjin, ChinaDepartment of Nuclear Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, ChinaLiaoning Cancer Hospital & Institute, Clinical Skills Training Center, Shenyang, ChinaDepartment of Joint and Sports Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, ChinaKey Laboratory of Molecular Mechanism for Repair and Remodeling of Orthopaedic Diseases, Dalian, Liaoning, ChinaDepartment of Joint and Sports Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, ChinaKey Laboratory of Molecular Mechanism for Repair and Remodeling of Orthopaedic Diseases, Dalian, Liaoning, ChinaObjectiveThis study aims to understand the current status and trend of the disease burden of osteoarthritis (OA) in people over 30 years old in China from 1990 to 2021 and identify the priority population groups, to provide reference data for the prevention and treatment of OA in China.MethodsThe Global Burden of Disease Study 2021 was used to describe the incidence, prevalence, and disability-adjusted life years (DALYs) of OA in adult aged 30 years or older in China by sex and age groups, which was used to analyze the disease burden of OA from 1990 to 2021. The joinpoint regression model and age-period-cohort model were used to characterize the temporal trend.ResultsIn 2021, the number of OA prevalence in China was about 152.85 million, and the number of incidences was about 11.65 million. The age-standardized prevalence rate (ASPR), age-standardized incidence rate (ASIR) and age-standardized DALYs rate (ASDR) of OA in China are lower than those in developed countries such as Korea, the United States of America and Japan, but higher than those in India. Knee osteoarthritis had the highest ASPR and ASDR. The highest incidence rate was 50–54 years, and the highest prevalence and DALYs rate were in the age group of patients over 95 years old. The incidence rate of women in all age groups is higher than that of men. From 1990 to 2021, the ASIR, ASPR and ASDR of OA in China roughly showed an increasing trend year by year. The age-period-cohort analysis showed that the peak age groups for longitudinal age incidence of OA in China from 1992 to 2021 were 50–54 years and 80–84 years. We found that the OA incidence was highest in the period 2017–2021.ConclusionThe disease burden of OA in those over 30 years old in China from 1990 to 2021 will become more and more serious, and the target population for primary prevention is the female population under 50 years old. The development of a scientific and effective comprehensive prevention and treatment program for OA is imminent.https://www.frontiersin.org/articles/10.3389/fpubh.2024.1478710/fullGlobal Burden of Disease Studyosteoarthritisincidenceprevalencedisability-adjusted life yearsChina |
| spellingShingle | Jiahui Liang Jiahui Liang Yue Wang Fei Yu Guichun Jiang Weiguo Zhang Weiguo Zhang Kang Tian Kang Tian Evaluation of the osteoarthritis disease burden in China from 1990 to 2021: based on the Global Burden of Disease Study 2021 Frontiers in Public Health Global Burden of Disease Study osteoarthritis incidence prevalence disability-adjusted life years China |
| title | Evaluation of the osteoarthritis disease burden in China from 1990 to 2021: based on the Global Burden of Disease Study 2021 |
| title_full | Evaluation of the osteoarthritis disease burden in China from 1990 to 2021: based on the Global Burden of Disease Study 2021 |
| title_fullStr | Evaluation of the osteoarthritis disease burden in China from 1990 to 2021: based on the Global Burden of Disease Study 2021 |
| title_full_unstemmed | Evaluation of the osteoarthritis disease burden in China from 1990 to 2021: based on the Global Burden of Disease Study 2021 |
| title_short | Evaluation of the osteoarthritis disease burden in China from 1990 to 2021: based on the Global Burden of Disease Study 2021 |
| title_sort | evaluation of the osteoarthritis disease burden in china from 1990 to 2021 based on the global burden of disease study 2021 |
| topic | Global Burden of Disease Study osteoarthritis incidence prevalence disability-adjusted life years China |
| url | https://www.frontiersin.org/articles/10.3389/fpubh.2024.1478710/full |
| work_keys_str_mv | AT jiahuiliang evaluationoftheosteoarthritisdiseaseburdeninchinafrom1990to2021basedontheglobalburdenofdiseasestudy2021 AT jiahuiliang evaluationoftheosteoarthritisdiseaseburdeninchinafrom1990to2021basedontheglobalburdenofdiseasestudy2021 AT yuewang evaluationoftheosteoarthritisdiseaseburdeninchinafrom1990to2021basedontheglobalburdenofdiseasestudy2021 AT feiyu evaluationoftheosteoarthritisdiseaseburdeninchinafrom1990to2021basedontheglobalburdenofdiseasestudy2021 AT guichunjiang evaluationoftheosteoarthritisdiseaseburdeninchinafrom1990to2021basedontheglobalburdenofdiseasestudy2021 AT weiguozhang evaluationoftheosteoarthritisdiseaseburdeninchinafrom1990to2021basedontheglobalburdenofdiseasestudy2021 AT weiguozhang evaluationoftheosteoarthritisdiseaseburdeninchinafrom1990to2021basedontheglobalburdenofdiseasestudy2021 AT kangtian evaluationoftheosteoarthritisdiseaseburdeninchinafrom1990to2021basedontheglobalburdenofdiseasestudy2021 AT kangtian evaluationoftheosteoarthritisdiseaseburdeninchinafrom1990to2021basedontheglobalburdenofdiseasestudy2021 |